Live Webinar on "How to Invest successfully to reach goals without losing sleep" Sign up for Live Webinar

Strides Pharma Science submits press release

27 Aug 2019

Strides Pharma Science has informed about submission of press release issued by the Company titled: ‘Strides acquires USFDA approved manufacturing facility in the US’.

The above information is a part of company’s filings submitted to BSE.

Related Strides Pharma Science Ltd. Links:

Strides Pharma Scien Share Price

599.25 -15.45 (-2.51%) Sep 24, 18:01
1 Year Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 769.70
Cipla 967.00
Dr. Reddy's Lab 4792.80
Aurobindo Pharma 722.10
Lupin 926.20
View more..
Sensex vs Strides Pharma Scien
Puchho Befikar
SEBI Registered: Investment Adviser - INA000013323

Callback